Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Antony Prabhu, A."'
Autor:
Abhilash, P.K. a, Jegajeevanram, P. b, c, Prabu, P. d, Abdur Rahman, M. e, ⁎, Antony Prabhu, A. f, Reyaz Ali Sahib, K. g, Govindasamy, Chandramohan h, Khan, Muhammad Ibrar h, Varaprasad, Kokkarachedu i, Arulselvan, Palanisamy j
Publikováno v:
In Journal of the Indian Chemical Society January 2025 102(1)
Autor:
Deena Dayal, S., Pushpa Rani, V., Antony Prabhu, D., Rajeshkumar, Shanmugam, David, Deon, Francis, Jofy
Publikováno v:
In Microbial Pathogenesis December 2024 197
Autor:
Pravin Kesarwani, Shiva Kant, Yi Zhao, Antony Prabhu, Katie L. Buelow, C. Ryan Miller, Prakash Chinnaiyan
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-16 (2023)
The upstream metabolism of tryptophan has been described as a metabolic node in glioblastoma. Here the authors show that the downstream metabolism of tryptophan, resulting in the accumulation of quinolinate in glioblastoma, contributes to pro-tumorig
Externí odkaz:
https://doaj.org/article/32c755725f2f4c8ea8e1e1e537931158
Autor:
Swamy Chinamilli, N.V.S., Azhagarsamy, P., Antony Prabhu, D., Rajesh, S., Lokesh Kumar, P.J., Selvan, T.A., Viswanathan, A., Madhankumar, S.
Publikováno v:
In Materials Today: Proceedings 2023 72 Part 4:2464-2468
Autor:
Vijayakumar, Rajendran, Viji, Arangarajan, Vanasundari, Karuppaiya, Balachandran, Vadivel, Arockia Dass, Antony Prabhu
Publikováno v:
Crystal Research & Technology; May2024, Vol. 59 Issue 5, p1-13, 13p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
N.V.S. Swamy Chinamilli, P. Azhagarsamy, D. Antony Prabhu, S. Rajesh, P.J. Lokesh Kumar, T.A. Selvan, A. Viswanathan, S. Madhankumar
Publikováno v:
Materials Today: Proceedings. 72:2464-2468
Autor:
Muthu Vijayasarathy, Yesudass Antony Prabhu, Selvan Pavithra, Selvaraj Jothi Prabha, Tingirikari Jagan Mohan Rao
Publikováno v:
Prebiotics and Probiotics in Disease Regulation and Management. :27-59
Autor:
Prakash Chinnaiyan, C. Ryan Miller, George D. Wilson, Katie L. Buelow, Stewart F. Graham, Praveen Kumar, Shiva Kant, Antony Prabhu, Pravin Kesarwani
Purpose: Immune checkpoint inhibitors designed to revert tumor-induced immunosuppression have emerged as potent anticancer therapies. Tryptophan metabolism represents an immune checkpoint, and targeting this pathway's rate-limiting enzyme IDO1 is act
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5ba580291ee898eb8f3e43e00e5093d
https://doi.org/10.1158/1078-0432.c.6527529
https://doi.org/10.1158/1078-0432.c.6527529
Autor:
Prakash Chinnaiyan, C. Ryan Miller, George D. Wilson, Katie L. Buelow, Stewart F. Graham, Praveen Kumar, Shiva Kant, Antony Prabhu, Pravin Kesarwani
Supplemental Figures 1, 2, 3 and 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dadb4332afc63c53352cc36e44e0b55
https://doi.org/10.1158/1078-0432.22470348
https://doi.org/10.1158/1078-0432.22470348